Data Repository

Expression data from MDA-MB-231 breast cancer cell lines exposed to DMSO control and UF010. Expression profiling by array (GSE56823). 

High throughput gene expression data from MDA-MB-231 breast cancer cell lines with DAXX Knockdown, DAXX WT overexpression (OE), and DAXX SUMO interacting motif mutant (DSM) overexpression (DSM OW). Expression profiling by high throughput sequencing (GSE192420). 

Expression data from MDA-MB-231 breast cancer cell lines with DAXX overexpression (OE) and DAXX SUMO interacting motif mutant (DSM) overexpression (DSM OE). Expression profiling by array (GSE223583).

Expression data from MCF-7 cells treated with p300 KAT inhibitor A-485. Expression profiling by array (GSE172175). 

MCF-7 cells treated with p300 KAT inhibitor A-485. Expression profiling by array (GSE172178). 

The role of chemerin in clear cell renal cell carcinoma. Expression profiling by high throughput sequencing (GSE159716).

Expression data from MDA-MB-231 breast cancer cell lines with DAXX Knockdown. Expression profiling by array (GSE190596).

Medulloblastoma cerebrospinal fluid reveals hypoxic indicators (metabolites and lipids) and cancer-specific RNAs. Expression profiling by high throughput sequencing  (GSE189919). 

Aortic single-cell RNA sequencing in ACTA2 R179 variants. Expression profiling by high throughput sequencing (GSE201091).

AGXT overexpression during nonalcoholic steatohepatitis in mice. Expression profiling by high throughput sequencing (GSE224097).

The oncogenic circular RNA circ_63706 is a potential therapeutic target in sonic hedgehog-subtype childhood medulloblastomas. Expression profiling by high throughput sequencing (GSE216687).

Niclosamide as a chemical probe for analyzing SARS-CoV-2 modulation of host cell lipid metabolism. Expression profiling by high throughput sequencing (GSE178157). 

RNA sequencing analysis of stable medulloblastoma DAOY, D425, and CHLA01 cells expressing vector only (V/O) or miR-211. Expression profiling by high throughput sequencing (GSE188813).

miRNA expression profile in human medulloblastoma cell lines. Non-coding RNA profiling by high throughput sequencing (GSE240544). 

Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins. Expression profiling by array (GSE285215). 

Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins [RNA-seq]. Expression profiling by high throughput sequencing (GSE285216). 

CHD1 Loss Hijacks SREBP2-mediated Cholesterol Biosynthesis to Fuel SPOP-deficient Prostate Cancer and Confers Resistance to Castration [scRNA-seq]. Expression profiling by high throughput sequencing (GSE273102). 

Genome-wide H3K27ac deposition in MCF-7 cells treated with p300 KAT inhibitor A-485. Genome binding/occupancy profiling by high throughput sequencing (GSE172174). 

DAXX genome binding/occupancy profiling by high throughput ChIP sequencing. Genome binding/occupancy profiling by high throughput sequencing (GSE190783). 

p53 dimers elicit unique tumor suppressive activities through an altered metabolic program [ATAC-seq]. Genome binding/occupancy profiling by high throughput sequencing (GSE220961).

Genetic and pharmacological targeting of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis. Methylation profiling by high throughput sequencing (GSE265985). 

Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins [ChIP-seq]. Genome binding/occupancy profiling by high throughput sequencing (GSE285287).

Cancer cells avoid ferroptosis induced by immune cells via fatty acid binding proteins [ATAC-seq]. Genome binding/occupancy profiling by high throughput sequencing (GSE285288). 

CHD1 Loss Hijacks SREBP2-mediated Cholesterol Biosynthesis to Fuel SPOP-deficient Prostate Cancer and Confers Resistance to Castration. Genome binding/occupancy profiling by high throughput sequencing (GSE272802). 

Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosis. https://zenodo.org/records/17187056 

Discrepancies in Biomarker Identification in Peak-Picking Strategies in Untargeted Metabolomics Analyses of Cells, Tissues, and Biofluids. https://zenodo.org/records/15499522

CerS2 is a druggable target in triple-negative breast cancer. https://zenodo.org/records/16803523

Multiomics analysis of concurrent MASH and atherosclerosis in male and female mice. https://zenodo.org/records/14025184

Ion suppression correction and data normalization in metabolomics. https://zenodo.org/records/14285171

Multi-omic mass spectrometry for investigating mechanisms of drug toxicity. https://zenodo.org/records/15051936

Receptor-mediated control of lipid metabolism through GPR1 and CMKLR1 in renal cell carcinoma. https://zenodo.org/records/10914396

Examination of the effect of nocadazole treatment on lipidomics. https://zenodo.org/records/10059819

Niclosamide as a chemical probe for analyzing SARS-CoV-2 modulation of host cell lipid metabolism. https://zenodo.org/uploads/8381788